New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccination

[1]  M. Humbert,et al.  The role of neutralizing antibodies in HIV infection. , 2006, AIDS reviews.

[2]  Ellis L. Reinherz,et al.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles , 2004, Immunogenetics.

[3]  J. Ulmer,et al.  Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design , 2004, Expert review of vaccines.

[4]  Ellis L Reinherz,et al.  Peptide Variants of Viral CTL Epitopes Mediate Positive Selection and Emigration of Ag-Specific Thymocytes In Vivo1 , 2004, The Journal of Immunology.

[5]  R. Proia,et al.  Expression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration* , 2004, Journal of Biological Chemistry.

[6]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[7]  R. Proia,et al.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.

[8]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[9]  R. Tampé,et al.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Rosen,et al.  Egress: a receptor‐regulated step in lymphocyte trafficking , 2003, Immunological reviews.

[11]  J. Cyster Lymphoid organ development and cell migration , 2003, Immunological reviews.

[12]  Pamela S. Ohashi,et al.  TCR Binding Kinetics Measured with MHC Class I Tetramers Reveal a Positive Selecting Peptide with Relatively High Affinity for TCR 1 , 2003, The Journal of Immunology.

[13]  S. Gawrieh,et al.  Neutralizing antibodies in hepatitis C virus infection: a review of immunological and clinical characteristics. , 2003, Gastroenterology.

[14]  W. Savino,et al.  Thymocyte migration: an affair of multiple cellular interactions? , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[16]  G. Schneider,et al.  A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses. , 2002, Immunity.

[17]  D. Burton Antibodies, viruses and vaccines , 2002, Nature Reviews Immunology.

[18]  J. Miller,et al.  The discovery of thymus function and of thymus‐derived lymphocytes , 2002, Immunological reviews.

[19]  Hidehiro Kishimoto,et al.  The thymus and negative selection , 2002, Immunological reviews.

[20]  C. Feng,et al.  A potential role for CD69 in thymocyte emigration. , 2002, International immunology.

[21]  Jia-huai Wang,et al.  Structural basis of T cell recognition of peptides bound to MHC molecules. , 2002, Molecular immunology.

[22]  P. Jensen,et al.  Positive Selection of Cd4+ T Cells Is Induced in Vivo by Agonist and Inhibited by Antagonist Peptides , 2001, The Journal of experimental medicine.

[23]  A. Sette,et al.  In Vivo Selection of a Lymphocytic Choriomeningitis Virus Variant That Affects Recognition of the GP33-43 Epitope by H-2Db but Not H-2Kb , 2001, Journal of Virology.

[24]  D. Wiley,et al.  T Cell Receptor–MHC Interactions up Close , 2001, Cell.

[25]  M. Bevan,et al.  Role of chemokines in thymocyte development. , 2000, Seminars in immunology.

[26]  A. Plückthun,et al.  Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex. , 2000, Journal of molecular biology.

[27]  W. Savino,et al.  Neuroendocrine control of thymus physiology. , 2000, Endocrine reviews.

[28]  E. Reinherz,et al.  Thymic selection is influenced by subtle structural variation involving the p4 residue of an MHC class I‐bound peptide , 2000, European journal of immunology.

[29]  M. Bevan,et al.  Selecting and maintaining a diverse T-cell repertoire , 1999, Nature.

[30]  M. Hilleman Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology , 1999, Immunological reviews.

[31]  P. Allen,et al.  A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor–Ligand Complex , 1999, The Journal of experimental medicine.

[32]  E. Reinherz,et al.  Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Kioussis,et al.  Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Kioussis,et al.  Interactions with multiple peptide ligands determine the fate of developing thymocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Hoffman,et al.  Research toward vaccines against malaria , 1998, Nature Medicine.

[36]  A. Smolyar,et al.  Identification of a common docking topology with substantial variation among different TCR–peptide–MHC complexes , 1998, Current Biology.

[37]  T. Godal,et al.  Malaria vaccine development: current status. , 1998, Parasitology today.

[38]  H. Grey,et al.  Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Wiley,et al.  Antigenic peptide binding by class I and class II histocompatibility proteins. , 1994, Structure.

[40]  S. Tonegawa,et al.  Evidence for a differential avidity model of T cell selection in the thymus , 1994, Cell.

[41]  L. Spain,et al.  A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. , 1994, Journal of immunology.

[42]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[43]  P. Allen,et al.  Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.

[44]  B. Haynes,et al.  Cell adhesion molecules involved in intrathymic T cell development. , 1993, Seminars in immunology.

[45]  D. Kioussis,et al.  Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Korber,et al.  Signature pattern analysis: a method for assessing viral sequence relatedness. , 1992, AIDS research and human retroviruses.

[47]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[48]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[49]  B. Korber,et al.  HIV-1 intrapatient sequence diversity in the immunogenic V3 region. , 1991, AIDS research and human retroviruses.

[50]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[51]  H. Pircher,et al.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.

[52]  A. Dalmasso,et al.  THE ROLE OF THE THYMUS IN DEVELOPMENT OF IMMUNOLOGIC CAPACITY IN RABBITS AND MICE , 1962, The Journal of experimental medicine.

[53]  B. Waksman,et al.  ROLE OF THE THYMUS IN IMMUNE REACTIONS IN RATS , 1962, The Journal of experimental medicine.

[54]  B. Waksman,et al.  ROLE OF THE THYMUS IN IMMUNE REACTIONS IN RATS , 1962, The Journal of experimental medicine.

[55]  M. Carroll,et al.  Monitoring of human immunological responses to vaccinia virus. , 2004, Methods in molecular biology.

[56]  C. Muller,et al.  Neutralizing B cell response in measles. , 2002, Viral immunology.

[57]  L. Nguyen,et al.  Contribution of LCMV transgenic models to understanding T lymphocyte development, activation, tolerance, and autoimmunity. , 2002, Current topics in microbiology and immunology.

[58]  K. Garcia,et al.  Structural basis of T cell recognition. , 1999, Annual review of immunology.

[59]  M. Bevan,et al.  Selecting and maintaining a diverse T-cell repertoire , 1999, Nature.

[60]  B. Fowlkes,et al.  Selective events in T cell development. , 1994, Annual review of immunology.